BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27830724)

  • 1. Activation of AMPKα mediates additive effects of solamargine and metformin on suppressing MUC1 expression in castration-resistant prostate cancer cells.
    Xiang S; Zhang Q; Tang Q; Zheng F; Wu J; Yang L; Hann SS
    Sci Rep; 2016 Nov; 6():36721. PubMed ID: 27830724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk of NF-κB/P65 and LncRNA HOTAIR-Mediated Repression of MUC1 Expression Contribute to Synergistic Inhibition of Castration-Resistant Prostate Cancer by Polyphyllin 1-Enzalutamide Combination Treatment.
    Xiang S; Zou P; Wu J; Zheng F; Tang Q; Zhou J; Hann SS
    Cell Physiol Biochem; 2018; 47(2):759-773. PubMed ID: 29807357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of PI3-K/Akt and reduction of SP1 and p65 expression increase the effect of solamargine on suppressing EP4 expression in human lung cancer cells.
    Chen Y; Tang Q; Wu J; Zheng F; Yang L; Hann SS
    J Exp Clin Cancer Res; 2015 Dec; 34():154. PubMed ID: 26689593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of curcumin and bicalutamide enhanced the growth inhibition of androgen-independent prostate cancer cells through SAPK/JNK and MEK/ERK1/2-mediated targeting NF-κB/p65 and MUC1-C.
    Li J; Xiang S; Zhang Q; Wu J; Tang Q; Zhou J; Yang L; Chen Z; Hann SS
    J Exp Clin Cancer Res; 2015 May; 34(1):46. PubMed ID: 25971429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of Solamargine and Metformin Strengthens IGFBP1 Gene Expression Through Inactivation of Stat3 and Reciprocal Interaction Between FOXO3a and SP1.
    Tang Q; Zheng F; Wu J; Xiao Q; Li L; Hann SS
    Cell Physiol Biochem; 2017; 43(6):2310-2326. PubMed ID: 29073599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chinese herbal medicine Fuzheng Kang-Ai decoction sensitized the effect of gefitinib on inhibition of human lung cancer cells through inactivating PI3-K/Akt -mediated suppressing MUC1 expression.
    Li L; Wang S; Zheng F; Wu W; Hann SS
    J Ethnopharmacol; 2016 Dec; 194():918-929. PubMed ID: 27989877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting EP4 downstream c-Jun through ERK1/2-mediated reduction of DNMT1 reveals novel mechanism of solamargine-inhibited growth of lung cancer cells.
    Chen Y; Tang Q; Xiao Q; Yang L; Hann SS
    J Cell Mol Med; 2017 Feb; 21(2):222-233. PubMed ID: 27620163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucin 1 Regulates Cox-2 Gene in Pancreatic Cancer.
    Nath S; Roy LD; Grover P; Rao S; Mukherjee P
    Pancreas; 2015 Aug; 44(6):909-17. PubMed ID: 26035123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification of MUC1 in prostate cancer metastasis and CRPC development.
    Wong N; Major P; Kapoor A; Wei F; Yan J; Aziz T; Zheng M; Jayasekera D; Cutz JC; Chow MJ; Tang D
    Oncotarget; 2016 Dec; 7(50):83115-83133. PubMed ID: 27825118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MUC1 protein induces urokinase-type plasminogen activator (uPA) by forming a complex with NF-κB p65 transcription factor and binding to the uPA promoter, leading to enhanced invasiveness of cancer cells.
    Mori Y; Akita K; Tanida S; Ishida A; Toda M; Inoue M; Yashiro M; Sawada T; Hirakawa K; Nakada H
    J Biol Chem; 2014 Dec; 289(51):35193-204. PubMed ID: 25371209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUC1-C oncoprotein functions as a direct activator of the nuclear factor-kappaB p65 transcription factor.
    Ahmad R; Raina D; Joshi MD; Kawano T; Ren J; Kharbanda S; Kufe D
    Cancer Res; 2009 Sep; 69(17):7013-21. PubMed ID: 19706766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of EZH2 via activation of SAPK/JNK and reduction of p65 and DNMT1 as a novel mechanism in inhibition of human lung cancer cells by polyphyllin I.
    Li L; Wu J; Zheng F; Tang Q; Wu W; Hann SS
    J Exp Clin Cancer Res; 2016 Jul; 35(1):112. PubMed ID: 27421653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solamargine inhibits the growth of hepatocellular carcinoma and enhances the anticancer effect of sorafenib by regulating HOTTIP-TUG1/miR-4726-5p/MUC1 pathway.
    Tang Q; Li X; Chen Y; Long S; Yu Y; Sheng H; Wang S; Han L; Wu W
    Mol Carcinog; 2022 Apr; 61(4):417-432. PubMed ID: 35040191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solamargine inhibits gastric cancer progression by regulating the expression of lncNEAT1_2 via the MAPK signaling pathway.
    Fu R; Wang X; Hu Y; Du H; Dong B; Ao S; Zhang L; Sun Z; Zhang L; Lv G; Ji J
    Int J Oncol; 2019 May; 54(5):1545-1554. PubMed ID: 30864686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin represses cancer cells via alternate pathways in N-cadherin expressing vs. N-cadherin deficient cells.
    Ge R; Wang Z; Wu S; Zhuo Y; Otsetov AG; Cai C; Zhong W; Wu CL; Olumi AF
    Oncotarget; 2015 Oct; 6(30):28973-87. PubMed ID: 26359363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Constitutive Intrinsic Inflammatory Signaling Circuit Composed of miR-196b, Meis2, PPP3CC, and p65 Drives Prostate Cancer Castration Resistance.
    Jeong JH; Park SJ; Dickinson SI; Luo JL
    Mol Cell; 2017 Jan; 65(1):154-167. PubMed ID: 28041912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursolic acid inhibited growth of hepatocellular carcinoma HepG2 cells through AMPKα-mediated reduction of DNA methyltransferase 1.
    Yie Y; Zhao S; Tang Q; Zheng F; Wu J; Yang L; Deng S; Hann SS
    Mol Cell Biochem; 2015 Apr; 402(1-2):63-74. PubMed ID: 25547067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
    Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H
    Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer.
    Babcook MA; Shukla S; Fu P; Vazquez EJ; Puchowicz MA; Molter JP; Oak CZ; MacLennan GT; Flask CA; Lindner DJ; Parker Y; Daneshgari F; Gupta S
    Mol Cancer Ther; 2014 Oct; 13(10):2288-302. PubMed ID: 25122066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer.
    Yasumizu Y; Rajabi H; Jin C; Hata T; Pitroda S; Long MD; Hagiwara M; Li W; Hu Q; Liu S; Yamashita N; Fushimi A; Kui L; Samur M; Yamamoto M; Zhang Y; Zhang N; Hong D; Maeda T; Kosaka T; Wong KK; Oya M; Kufe D
    Nat Commun; 2020 Jan; 11(1):338. PubMed ID: 31953400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.